Intron associated with myotonic dystrophy type 2 and methods of use
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides methods for identifying individuals not at risk for developing myotonic dystrophy type 2 (DM2), and individuals that have or at risk for developing DM2. The present invention also provides isolated polynucleotides that include a repeat tract within intron 1 of the zinc finger protein 9.
10 Citations
23 Claims
-
1-16. -16. Canceled.
-
17. An isolated polynucleotide comprising a nucleotide sequence selected from the group consisting of about nucleotides 1-14468 of SEQ ID NO:
- 1, about nucleotides 14474-22400 of SEQ ID NO;
1, and the complements thereof.
- 1, about nucleotides 14474-22400 of SEQ ID NO;
-
18. An isolated polynucleotide comprising about nucleotides 17501-17701 of SEQ ID NO:
- 1, and the complements thereof.
-
19. An isolated polynucleotide comprising about nucleotides 17501-17701 of SEQ ID NO:
- 1 and a repeat tract, and the complements thereof.
-
20. An isolated polynucleotide comprising about nucleotides 17858-18062 of SEQ ID NO:
- 1, and the complements thereof.
-
21. An isolated polynucleotide comprising about nucleotides 17858-18062 of SEQ ID NO:
- 1 and a repeat tract, and the complements thereof.
-
22. An isolated polynucleotide comprising at least about 15 consecutive nucleotides from nucleotides 16701-17701 of SEQ ID NO:
- 1.
-
23. An isolated polynucleotide comprising at least about 15 consecutive nucleotides from nucleotides 17858-18862 of SEQ ID NO:
- 1.
Specification